E3 PreliminaryPreliminaryPEM requiredMechanisticPeer-reviewedReviewed
Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Maya, Jessica, Leddy, Sabrina M, Gottschalk, C Gunnar et al. · International journal of molecular sciences · 2023 · DOI
Quick Summary
Researchers studied immune cells called lymphocytes from ME/CFS patients and found that these cells use fatty acids (a type of fuel) differently than healthy people's immune cells do. When immune cells are activated or working hard, ME/CFS patients' cells rely more heavily on burning fat for energy compared to cells from healthy controls. This suggests that ME/CFS patients' immune systems may have a fundamental problem with how they fuel their cells.
Why It Matters
Understanding how ME/CFS immune cells produce and use energy may reveal why patients' immune systems appear dysfunctional and could explain some core symptoms like fatigue and post-exertional malaise. This research provides potential biomarkers and therapeutic targets, as correcting these metabolic abnormalities might improve immune function and patient outcomes.
Observed Findings
- All three lymphocyte types (NK cells, CD4+ T cells, CD8+ T cells) from ME/CFS patients showed increased lipid utilization compared to controls.
- ME/CFS immune cells expressed higher levels of proteins involved in fatty acid oxidation, particularly during activation and high energy demands.
- Specific cell subsets showed metabolic shifts, including CD4+ memory cells, CD4+ effector cells, CD8+ naïve cells, and CD8+ memory cells.
- Significant correlations were found between CD4+ T cell fatty acid metabolism measurements and patient demographic data in ME/CFS patients.
Inferred Conclusions
- ME/CFS lymphocytes demonstrate metabolic dysfunction characterized by altered fuel dependencies and increased reliance on fatty acid oxidation.
- These metabolic shifts occur particularly when immune cells are activated and under high energy demand, suggesting impaired energy metabolism during immune responses.
- The altered fuel dependencies may compromise T and NK cell effector function, potentially explaining some aspects of immune dysfunction in ME/CFS.
Remaining Questions
- Does the altered fatty acid metabolism directly impair the ability of ME/CFS immune cells to fight infections and function properly?
- Is the metabolic dysfunction in immune cells a cause or a consequence of ME/CFS, and what triggers these changes?
What This Study Does Not Prove
This study does not prove that altered fatty acid metabolism causes ME/CFS symptoms or that it is the primary disease mechanism—it demonstrates an association in a limited sample. The research does not establish whether these metabolic changes are primary (causing the disease) or secondary (resulting from it), nor does it directly test whether correcting these metabolic abnormalities would improve symptoms.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionFatigue
Biomarker:MetabolomicsGene ExpressionBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory OnlyPEM Not Defined
Metadata
- DOI
- 10.3390/ijms24032010
- PMID
- 36768336
- Review status
- Editor reviewed
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 12 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.